In neurocritical care, the gold standard method is intracranial pressure (ICP) monitoring for the patient's lifesaving. Since it is an invasive method, it is desirable to use an alternative, noninvasive technique. The computerized real-time invasive cerebral blood flow (CBF) autoregulation (AR) monitoring calculates the status of CBF AR, called the pressure reactivity index (PRx). Studies documented that the electrical impedance of the head (Rheoencephalography – REG) can detect the status of CBF AR (REGx) and ICP noninvasively. We aimed to test REG to reflect ICP and CBF AR. For nineteen healthy subjects we recorded bipolar bifrontal and bitemporal REG derivations and arm bioimpedance pulses with a 200 Hz sampling rate. The challenges were a 30-second breath-holding and head-down-tilt (HDT – Trendelenburg) position. Data were stored and processed offline. REG pulse wave morphology and REGx were calculated. The most relevant finding was the significant morphological change of the REG pulse waveform (2nd peak increase) during the HDT position. Breath-holding caused REG amplitude increase, but it was not significant. REGx in male and female group averages have similar trends during HDT by indicating the active status of CBF AR. The morphological change of REG pulse wave during HDT position was identical to ICP waveform change during increased ICP, reflecting decreased intracranial compliance. A correlation study between ICP and REG was initiated in neurocritical care patients. The noninvasive REG monitoring would also be useful in space research as well as in military medicine during the transport of wounded service members as well as for fighter pilots to indicate the loss of CBF and consciousness.
19 March 2023 in Journal of Clinical Monitoring and Computing
The loss of cerebral blood flow autoregulation is experienced after severe neurological injuries. Its impairment leads to a cascade of secondary neurological injuries that often follow the primary neurological insult. However, although its maintenance is important, cerebral autoregulation monitoring remains and does not follow consistent clinical standards. The traditional neurocritical monitoring method is invasive intracranial pressure monitoring. Several methods have also been tested for noninvasive neuromonitoring. Rheoencephalography is a form of non-invasive monitoring based on bioimpedance measurement; however, it is not used in routine clinical practice today. This review presents selected results of in-vitro and in-vivo studies evaluating the rheoencephalogram pulse waveform quantification during cerebral blood flow alterations, correlations with the intracranial pressure and other cerebral blood flow measuring modalities, and calculation of the rheoencephalogram-based autoregulation index. A total number of 1027 human and 638 animal measurements were involved. An in-vitro study documented the correlation between Doppler ultrasound flow and bioimpedance. In-vivo animal and human studies established a correlation with other modalities such as laser Doppler flow, carotid flow, near-infrared spectroscopy, and intracranial pressure as well as invasive and noninvasive cerebral blood flow autoregulation indexes. Studies documented that rheoencephalogram reflects cerebral volume change, cerebrovascular reactivity, intracranial pressure, and cerebral blood flow autoregulation. Human measurements documented that rheoencephalogram pulse wave morphology changes (peak 2) and that cerebral blood flow autoregulation’s active/ passive status and peak 2 increases during the Trendelenburg position. These studies support the idea that rheoencephalography can be considered as a future non-invasive neuromonitoring modality.
Purpose Cerebral blood flow (CBF) autoregulation (AR) can be monitored using invasive modalities, such as intracranial pressure (ICP) and arterial blood pressure (ABP) to calculate the CBF AR index (PRx). Monitoring PRx can reduce the extent of secondary brain damage in patients. Rheoencephalography (REG) is an FDA-approved non-invasive method to measure CBF. REGx, a CBF AR index, is calculated from REG and arm bioimpedance pulse waves. Our goal was to test REG for neuromonitoring. Methods 28 measurement sessions were performed on 13 neurocritical care patients. REG/arm bioimpedance waveforms were recorded on a laptop using a bioimpedance amplifier and custom-built software. The same program was used for offline data processing. Results Case #1: The patient’s mean REGx increased from − 0.08 on the first day to 0.44 on the second day, indicating worsening intracranial compliance (ICC) (P < 0.0001, CI 0.46–0.58). Glasgow Coma Scale (GCS) was 5 on both days. Case #2: REGx decreased from 0.32 on the first recording to 0.07 on the last (P = 0.0003, CI-0.38 to -0.12). GCS was 7 and 14, respectively. Case #3: Within a 36-minute recording, REGx decreased from 0.56 to -0.37 (P < 0.0001, 95%, CI: -1.10 to -0.76). Central venous pressure changed from 14 to 9 mmHg. REG pulse wave morphology changed from poor ICC to good ICC morphology. Conclusion Bioimpedance recording made it possible to quantify the active/passive status of CBF AR, indicate the worsening of ICC, and present it in real-time. REGx can be a suitable, non-invasive alternative to PRx for use in head-injured patients.
To create an algorithm to detect rheoencephalographic (REG) pulse wave second peak increase, which may detect an increase in intracranial pressure (ICP). REG was measured in 19 healthy volunteers during control and a 15-degree head-down tilt (HDT), which caused an increase in ICP. We developed an algorithm for automatically calculating P1 and P2 from the REG pulse waveform. The result was compared to manual measurements during control and HDT positions. The automatic determination of the peaks’ time instants was considered a series of two-class decision problems in ±15-ms-wide sliding decision windows. We achieved an accuracy of 0.9826, a sensitivity of 0.7727, and a specificity of 0.9902. We used the correlation coefficient between manual measurements and automated data and the normalized mean absolute error (NMAE) metric to characterize the precision of peak amplitude value estimation. We achieved a high correlation (> 0.8) in 92% of all tests, and NMAE < 0.3 in 96%. The remaining cases were analyzed using Bland-Altman plots to uncover the main causes of differences. We tested the hypothesis of increasing P2 peak amplitude during HDT compared to the control position. In the female group, the number of significant increases was 4 out of 6 (67%), both in manual and automatic measurements. In the case of the male group’s manual measurements, 12 of 13 (92%), and the automatic calculation gave 10 of 13 (77%). The significance is to switch from invasive ICP to noninvasive REG to have the same information for decision-making at the bedside to save the lives of neurocritical care patients. Future REG correlation studies suggested using REG in neurocritical care monitoring, space research, and military medical practice.